Author, year | Study location | Sample size | Studied population, mean age (range) | Inclusion criteria | Exclusion criteria |
---|---|---|---|---|---|
Memantine | |||||
Biederman et al. (2017) [46] | USA | 26 | Adults, 15–57 (35.33) | • DSM-IV criteria • AISRS score ≥ 20 | • Clinically significant chronic medical conditions • IQ < 80 • Any unstable psychiatric condition • Drug or alcohol abuse • Pregnant or nursing females |
Findling et al. (2007) [32] | USA | 16 | Children, 6–12 (8.1) | • DSM-IV criteria • K-SADS-PL | • Any unstable psychiatric condition, except for oppositional defiant disorder • A general medical condition that might interfere with the conduct of the study |
Riahi et al. (2020) [47] | Iran | 39 | Children 6–12 (9.51) | • DSM-IV criteria • Conner’s score ≥ 20 | • A serious psychiatric disorder • History of lack of response to memantine • History of severe side effects associated with memantine and methylphenidate |
Mohammadi et al. (2015) [36] | Iran | 40 | Children, 6–11 (8.6) | • DSM-IV criteria • K-SADS-PL | • Other psychiatric disorders • Mental retardation (IQ < 70) • Clinically significant chronic medical condition • Current abuse or dependence on drugs in the last 6 months |
Mohammadzadeh et al. (2019) [48] | Iran | 40 | Adults, 18–45 (33.1) | • Parents of ADHD children • DSM‐IV • WURS | • Mental disability • The presence of any other psychiatric disorder • Substance or alcohol abuse (in a recent month) • Pregnant women • History of allergy to memantine • The presence of a serious medical illness |
Surman et al. (2013) [35] | USA | 34 | Adults, 18–60 (41.8) | • DSM-IV • AISRS inattentive score ≥ 14 • CGI-S ≥ 4 | • Any history of renal impairment, hepatic impairment, an organic brain disorder, a seizure disorder • IQ < 75 • Clinically unstable psychiatric conditions • History of substance dependence or abuse • Pregnant or nursing females |
Donepezil | |||||
Cubo et al. (2008) [37] | Spain | 20 | Children and adolescents, 7–17 (11.3) | • DSM-IV criteria | • Evidence of a secondary tic disorder • Mental retardation or autism • Diseases that would be expected to alter the safety profile of donepezil • All females of reproductive age were required to provide a negative urine pregnancy test |
Doyle et al. (2006) [22] | NA (case series) | 8 | Adolescents, 10–17 (13.5) | • DSM-IV criteria | – |
Wilens et al. (2000) [39] | NA (case series) | 5 | Children and adolescents, 8–17 (13.6) | • DSM-IV criteria | – |
Wilens et al. (2005) [38] | USA | 13 | Children and adults (26) | • DSM-IV criteria | • Exclusionary comorbid conditions |
Galantamine | |||||
Biederman et al. (2006) [40] | USA | 28 | Adults, 18–55 (35.9) | • DSM-IV criteria | • Clinically significant chronic medical conditions • IQ lower than 80 • Clinically unstable psychiatric conditions • Drug or alcohol abuse or dependence within the 6 months preceding the study • Pregnant or breast-feeding women |